当前位置: 首页 > 医疗版 > 疾病专题 > 骨科 > 骨折 > 脊柱、脊髓损伤
编号:13268692
骨髓基质干细胞在治疗脊髓损伤中的应用(5)
http://www.100md.com 2018年11月5日 《中国医学创新》 2018年第31期
     [37] Pal R,Venkataramana N K,Bansal A,et al.Ex vivo expanded autologous bone marrow derived mesenchymal stromal cells in human spinal cord injury paraplegia a pilot clinical study[J].Cytotherapy,2009,11(7):897-911.

    [38] Syková E,Homola A,Mazanec R,et al.Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury[J].Cell Transplant,2006,15(8-9):675-687.

    [39] Moviglia G,Fernandez V R,Brizuela J,et al.Combined protocol of cell therapy for chronic spinal cord injury:report on the electrical and functional recovery of two patients[J].Cytotherapy,2006,8(3):202-209.

    [40] Saito F,Nakatani T,Iwase M,et al.Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation:the first clinical trial case report[J].J Trauma,2008,64(1):53-59.

    [41]趙廷宝,卢兆桐,赵凌云,等.骨髓间充质干细胞与嗅鞘细胞联合移植治疗脊髓损伤的早期观察[J].中国矫形外科杂志,2006,39(3):346-348.

    [42] Bhanot Y,Rao S,Ghosh D,et al.Autologous mesenchymal stem cells in chronic spinal cord injury[J].Br J Neurosurg,2011,25(4):516-522.

    (收稿日期:2018-05-15) (本文编辑:董悦), 百拇医药(杨国宏 潘艳明 赵富生)
上一页1 2 3 4 5


    参见:首页 > 医疗版 > 疾病专题 > 骨科 > 骨折 > 脊柱、脊髓损伤